Ikarian Capital, LLC Q4 2020 Filing
Filed February 12, 2021
Portfolio Value
$2.3B
Holdings
183
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (183 positions)
| Stock | Value |
|---|---|
INMBINMUNE BIO INC | $3.7M |
—CASI PHARMACEUTICALS INC | $3.7M |
PASGPASSAGE BIO INC | $3.5M |
ACRSACLARIS THERAPEUTICS INC | $3.5M |
XENEXENON PHARMACEUTICALS INC | $3.4M |
STTKSHATTUCK LABS INC | $3.4M |
PHATPHATHOM PHARMACEUTICALS INC | $3.3M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $3.3M |
ARNAEURARENA PHARMACEUTICALS INC | $3.3M |
—CHIASMA INC | $3.2M |
—CYCLACEL PHARMACEUTICALS INC | $3.1M |
—FREQUENCY THERAPEUTICS INC | $3.0M |
AGENEURAGENUS INC | $3.0M |
ACADACADIA PHARMACEUTICALS INC | $3.0M |
TREURTRILLIUM THERAPEUTICS INC | $2.9M |
—MERSANA THERAPEUTICS INC | $2.8M |
LQDALIQUIDIA CORPORATION | $2.8M |
PSTXUSDPOSEIDA THERAPEUTICS INC | $2.8M |
MDGLMADRIGAL PHARMACEUTICALS INC | $2.6M |
ICADUSDICAD INC | $2.6M |
NKTREURNEKTAR THERAPEUTICS | $2.5M |
TORCEURADICET BIO INC | $2.4M |
—PANACEA ACQUISITION CORP | $2.4M |
SP4PACHIEVE LIFE SCIENCES INC | $2.3M |
NBIXNEUROCRINE BIOSCIENCES INC | $2.3M |
—YUMANITY THERAPEUTICS INC | $2.3M |
—APPLIED GENETIC TECHNOLOGIES | $2.2M |
—GW PHARMACEUTICALS PLC | $2.2M |
NXTCNEXTCURE INC | $2.2M |
HROWHARROW HEALTH INC | $2.1M |
DCTHDELCATH SYS INC | $2.0M |
MBIOUSDMUSTANG BIO INC | $2.0M |
—DBV TECHNOLOGIES S A | $1.9M |
KNSAKINIKSA PHARMACEUTICALS LTD | $1.8M |
—BELLICUM PHARMACEUTICALS INC | $1.8M |
—BCTG ACQUISITION CORP | $1.7M |
OTICEUROTONOMY INC | $1.7M |
PBYIPUMA BIOTECHNOLOGY INC | $1.6M |
ATYRATYR PHARMA INC | $1.6M |
—CATABASIS PHARMACEUTICALS IN | $1.4M |
AUPHAURINIA PHARMACEUTICALS INC | $1.4M |
—GAMIDA CELL LTD | $1.3M |
—LONGVIEW ACQUISITION CORP | $1.2M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $1.2M |
FIXXEURHOMOLOGY MEDICINES INC | $1.1M |
—SYROS PHARMACEUTICALS INC | $1.1M |
CEMIUSDCHEMBIO DIAGNOSTICS INC | $1.0M |
ALECALECTOR INC | $870K |
ALTALTIMMUNE INC | $851K |
ETNBGBP89BIO INC | $799K |
IFRXINFLARX NV | $754K |
BDQMALBIREO PHARMA INC | $633K |
KALAKALA PHARMACEUTICALS INC | $594K |
—CERECOR INC | $536K |
RCUSARCUS BIOSCIENCES INC | $532K |
COGTCOGENT BIOSCIENCES INC | $469K |
—AERPIO PHARMACEUTICALS INC | $468K |
BMY-RBRISTOL-MYERS SQUIBB CO | $444K |
ASMBASSEMBLY BIOSCIENCES INC | $439K |
MREOMEREO BIOPHARMA GROUP PLC | $416K |
I9DNARBUTUS BIOPHARMA CORP | $408K |
—ASLAN PHARMACEUTICALS LTD | $405K |
—SUNESIS PHARMACEUTICALS INC | $398K |
RAPTEURRAPT THERAPEUTICS INC | $378K |
AVDLAVADEL PHARMACEUTICALS PLC | $366K |
BLUBELLUS HEALTH INC NEW | $306K |
—MILLENDO THERAPEUTICS INC | $289K |
PRAXPRAXIS PRECISION MEDICINES I | $275K |
INBXUSDINHIBRX INC | $266K |
—SOLENO THERAPEUTICS INC | $236K |
IVAINVENTIVA SA | $214K |
CRBPEURCORBUS PHARMACEUTICALS HLDGS | $174K |
EYPTEYEPOINT PHARMACEUTICALS INC | $119K |
—BAUDAX BIO INC | $101K |
—KINNATE BIOPHARMA INC | $79K |
RCKTROCKET PHARMACEUTICALS INC | $75K |
—TRANSLATE BIO INC | $67K |
NVLSEURALPINE IMMUNE SCIENCES INC | $60K |
—STEALTH BIOTHERAPEUTICS CORP | $57K |
—APTOSE BIOSCIENCES INC | $18K |
KPTIEURKARYOPHARM THERAPEUTICS INC | $12K |
CGENCOMPUGEN LTD | $6K |
—BCLS ACQUISITION CORP | $1K |
PreviousPage 2 of 2